MedPath

Efficacy and safety of hair loss suppression by additional scalp cooling during breast cancer chemotherapy

Not Applicable
Conditions
breast cancer
Registration Number
JPRN-UMIN000038946
Lead Sponsor
Showa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with malignant blood disease 2) Patients with cold allergies 3) Patients with cold agglutinin disease 4) Patients with a tumor on the scalp 5) Patients receiving high-dose anticancer drugs as pretreatment for stem cell transplantation 6) Patients undergoing head radiation therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of hair loss at the end of chemotherapy and during chemotherapy (CTCAE ver.4.0) Hair loss of eyebrows and eyelashes Whether wearing a hat or wig
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath